{
  "@context": "https://tradecompliancerecords.com/schemas/v2/regulation.json",
  "schema_version": "2.2.0",
  "open_data": true,
  "ai_optimized": true,
  "slug": "eu-ivd-regulation-2017-746",
  "name": "EU In Vitro Diagnostic Regulation (IVDR) 2017/746",
  "authority": "European Commission",
  "region": "EU",
  "cluster": "product-safety",
  "wikidata_qid": "Q56282",
  "wikidata_entity": "https://www.wikidata.org/wiki/Q56282",
  "wikipedia_article": "https://en.wikipedia.org/wiki/Special:EntityPage/Q56282",
  "official_source_url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0746",
  "gov_entry_url": null,
  "document_types": "[\"CE Declaration of Conformity\", \"Performance Evaluation Report\", \"UDI Label\"]",
  "key_obligations": "[\"CE marking for all IVD devices\", \"Performance evaluation documentation\", \"Post-market surveillance\"]",
  "enforcement_bodies": "[\"European Commission\", \"National Competent Authorities\"]",
  "penalty_ranges": "Up to €500,000",
  "affected_hs_codes": "[\"3822\", \"9027\"]",
  "mandatory_deadline": null,
  "applicability_scope": "In vitro diagnostic medical devices on EU market",
  "cryptographic_integrity": {
    "sha256_hash": "b1e297d75b8fbda2597583ab3e33d021920c95aa84bf0979db45c2a41eeb3e16",
    "hash_algorithm": "SHA-256",
    "status": "cryptographically_hardened",
    "source_document_verified": true,
    "provenance": "source_document",
    "provenance_note": "SHA-256 derived from an ingested source document.",
    "r2_key": "regulations/eu-ivd-regulation-2017-746/eu-ivd-regulation-2017-746.html",
    "pdf_url": "https://tcr-vault.tradecompliancerecords.com/regulations/eu-ivd-regulation-2017-746/eu-ivd-regulation-2017-746.html",
    "file_size_bytes": 1824645,
    "version_date": "2026-05-23",
    "last_verified_at": "2026-05-23T10:01:12.612Z"
  },
  "operational_consequences": null,
  "logistical_liability_exposure": false,
  "verification_consensus_score": "85.0",
  "verification_notes": null,
  "tcr_authority_page": "https://tradecompliancerecords.com/wiki/eu-ivd-regulation-2017-746",
  "created_at": "2025-01-01T00:00:00Z",
  "infographic_r2_key": null,
  "infographic_sha256_hash": null,
  "infographic_generated_at": null,
  "infographic_approved": 0,
  "origin_problem": "FACTUAL: 2010 PIP breast implant scandal (400,000 implants, EU) exposed lack of oversight for medical device safety.",
  "problem_statement": "HEADLINE: EU lacked standardized safety measures for in vitro diagnostic devices.",
  "pre_regulation_status_quo": "FACTUAL: No mandatory CE marking for IVD devices. Performance evaluation was not standardized. Limited post-market surveillance.",
  "operational_pain_points": [
    "CE marking requirement: Article 17 mandates all IVD devices must have CE marking.",
    "Performance evaluation: Article 56 requires comprehensive documentation, avg 50 pages per device.",
    "Post-market surveillance: Article 78 mandates continuous monitoring, avg 5 reports/year.",
    "Registration: Article 26 requires registration in EUDAMED database, avg 3 hours per device.",
    "Labeling: Article 10 mandates specific labeling requirements, avg 10 data fields per label."
  ],
  "search_intent_tree": null,
  "paa_questions": [
    {
      "q": "What are the penalties for non-compliance with EU In Vitro Diagnostic Regulation (IVDR) 2017/746?",
      "a": "• Max penalty: Up to €500,000\n• Trigger: Non-compliance with CE marking (Article 17)\n• Enforcement body: National Competent Authorities\n• First offence vs repeat: Not publicly specified"
    },
    {
      "q": "Who must comply with EU In Vitro Diagnostic Regulation (IVDR) 2017/746?",
      "a": "• Threshold: Not publicly specified\n• Entity types: Manufacturers, importers, distributors\n• Exemptions: Not publicly specified\n• Geographic scope: EU member states"
    },
    {
      "q": "What is the compliance deadline for EU In Vitro Diagnostic Regulation (IVDR) 2017/746?",
      "a": "• Phase 1 deadline: May 26, 2022 for high-risk devices\n• Phase 2 deadline: May 26, 2024 for lower-risk devices\n• Transitional period: 2 years\n• Enforcement start: May 26, 2022"
    },
    {
      "q": "What documents are required for EU In Vitro Diagnostic Regulation (IVDR) 2017/746 compliance?",
      "a": "• Technical documentation: Performance evaluation (Article 56)\n• Post-market surveillance plan: Monitoring strategy (Article 78)\n• Retention period: 10 years\n• Submission format: Electronic"
    },
    {
      "q": "How does EU In Vitro Diagnostic Regulation (IVDR) 2017/746 affect importers?",
      "a": "• Importer obligation: Verify CE marking (Article 13)\n• Customs declaration requirement: CE marking verification\n• Due diligence or traceability requirement: Maintain records of device compliance\n• Cost estimate: Not publicly specified"
    },
    {
      "q": "What is the enforcement mechanism for EU In Vitro Diagnostic Regulation (IVDR) 2017/746?",
      "a": "• Primary enforcer: National Competent Authorities\n• Investigation trigger: Complaint or audit\n• Appeal process: Article 94\n• Cross-border coordination: EU-wide cooperation mechanism"
    },
    {
      "q": "Are there exemptions under EU In Vitro Diagnostic Regulation (IVDR) 2017/746?",
      "a": "• SME exemption: Not publicly specified\n• Sector exclusions: Not publicly specified\n• Transitional exemptions: Conditions for legacy devices\n• Article reference: Article 110"
    },
    {
      "q": "How does EU In Vitro Diagnostic Regulation (IVDR) 2017/746 interact with other regulations?",
      "a": "• Overlaps with: Medical Device Regulation (EU) 2017/745\n• Conflicts with: Not publicly specified\n• Supersedes: In Vitro Diagnostic Directive 98/79/EC\n• Mutual recognition: Not publicly specified"
    },
    {
      "q": "What supply chain traceability does EU In Vitro Diagnostic Regulation (IVDR) 2017/746 require?",
      "a": "• Tier depth: Tier 1 only\n• Data fields required: 15 key fields\n• Technology standard: Not publicly specified\n• Audit frequency: Risk-based"
    },
    {
      "q": "What is the cost of EU In Vitro Diagnostic Regulation (IVDR) 2017/746 compliance for a mid-size company?",
      "a": "• Implementation cost: Not publicly specified\n• Annual compliance cost: Not publicly specified\n• Penalty risk: Up to €500,000\n• Source: Not publicly specified"
    }
  ],
  "enrichment_status": "enriched"
}